ALX Oncology Holdings Inc. (ALXO) vs AN2 Therapeutics, Inc. (ANTX)
ALX Oncology Holdings Inc. and AN2 Therapeutics, Inc. are both Biotechnology companies. ALX Oncology Holdings Inc. and AN2 Therapeutics, Inc. are of similar size ($187.4M and $184.5M). Across the 10 metrics below, AN2 Therapeutics, Inc. leads on 8 and ALX Oncology Holdings Inc. on 2.
Valuation
Profitability
| Metric | ALXO | ANTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (80.65%) | (50.12%) | (57.72%) |
| Return on assets | (63.16%) | (46.06%) | (49.22%) |
| Return on invested capital | (673.30%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack